Back to search results

Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations

Abroad (travel likely)RecruitingPHASE2

Conditions

Arteriovenous Malformations

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UCL, Brussels, Belgium

  • CHU Amiens, Amiens, France

    Contact: Principal Investigator (Bernard DEVAUCHELLE, MD, PhD)
    Sylvie TESTELIN, MD, PhD (Sub-investigator)

  • CHU Bordeaux, Bordeaux, France

  • CHU Dijon, Dijon, France

    Contact: Study coordinator (Pierre VABRES, MD PhD)
    Contact: Principal Investigator (Pierre VABRES, MD PhD)

  • CHRU Lille, Lille, France

  • HCL Lyon, Lyon, France

    Contact: Study coordinator (Pierre BRETON, MD PhD) · pierre.breton@chu-lyon.fr
    Contact: Study coordinator (Laurent GUIBAUD, MD PhD) · laurent.guibaud@chu-lyon.fr
    Contact: Principal Investigator (Pierre BRETON)
    Contact: Principal Investigator (Laurent GUIBAUD)

  • APHM, Marseille, France

    Contact: Study coordinator (Stéphanie MALLET, MD) · stephanie.mallet@ap-hm.fr
    Contact: Principal Investigator (Jean-Michel BARTOLI)
    Stéphanie MALLET, MD (Sub-investigator)

  • CHU Montpellier, Montpellier, France

  • CHU Nancy, Nancy, France

  • CHU Nice, Nice, France

  • APHP, Paris, France

  • CHU Strasbourg, Strasbourg, France

  • CHU Tours, Tours, France

Study leads

  • Bernard DEVAUCHELLE, MD, PhD

    Study Director

    CHU Amiens

  • Emmanuel MORELON, MD, PhD

    Study Chair

    HCL Lyon

View source on ClinicalTrials.gov(opens in a new tab)